• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿托伐他汀可减轻 Wistar 大鼠肝缺血/再灌注损伤。

Hepatic ischemia/reperfusion injury is diminished by atorvastatin in Wistar rats.

机构信息

Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.

Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico.

出版信息

Arch Med Res. 2014 Apr;45(3):210-6. doi: 10.1016/j.arcmed.2014.02.001. Epub 2014 Apr 13.

DOI:10.1016/j.arcmed.2014.02.001
PMID:24726586
Abstract

BACKGROUND AND AIMS

Temporal occlusion of the hepatoduodenal ligament (HDL) is often used during liver surgeries in order to reduce blood loss, resulting in ischemia/reperfusion injury (I/R). The aim of the study was to investigate the effects of atorvastatin (ATOR) on hepatic I/R injury and on serum levels of tumor necrosis factor-alpha (TNF-α), endothelin-1 (ET-1), antithrombin III (ATIII) and intracellular adhesion molecule-1 (ICAM-1).

METHODS

Liver ischemia was induced in Wistar rats by clamping the HDL for 60 min, followed by either 60 or 180 min reperfusion. Rats received either vehicle or 10 mg/kg ATOR before hepatic I/R. Control group received sham surgery. Livers were examined for histological damage and serum AST, ALT, TNF-α, ET-1, ATIII and ICAM-1 concentrations were measured.

RESULTS

After I/R, AST and ALT were significantly elevated, ATIII levels were significantly depleted, both TNF-α and ICAM-1 levels increased and ET-1 was significantly elevated (at 180 min). ATOR pretreatment attenuated these alterations and diminished histological injury scores.

CONCLUSIONS

Our results show that ATOR protects the liver from I/R injury.

摘要

背景与目的

在肝脏手术中,常采用阻断肝十二指肠韧带(HDL)的方法来减少失血,由此导致肝脏缺血再灌注损伤(I/R)。本研究旨在探讨阿托伐他汀(ATOR)对肝脏 I/R 损伤及血清肿瘤坏死因子-α(TNF-α)、内皮素-1(ET-1)、抗凝血酶 III(ATIII)和细胞间黏附分子-1(ICAM-1)水平的影响。

方法

采用夹闭 HDL 60 min 再灌注 60 或 180 min 的方法诱导 Wistar 大鼠肝脏缺血,然后分别给予载体或 10 mg/kg ATOR。对照组行假手术。检测肝脏组织学损伤,并测定血清 AST、ALT、TNF-α、ET-1、ATIII 和 ICAM-1 浓度。

结果

I/R 后,AST 和 ALT 显著升高,ATIII 水平显著下降,TNF-α和 ICAM-1 水平升高,ET-1 水平升高(180 min 时)。ATOR 预处理可减轻这些变化,降低组织学损伤评分。

结论

我们的结果表明,ATOR 可减轻肝脏 I/R 损伤。

相似文献

1
Hepatic ischemia/reperfusion injury is diminished by atorvastatin in Wistar rats.阿托伐他汀可减轻 Wistar 大鼠肝缺血/再灌注损伤。
Arch Med Res. 2014 Apr;45(3):210-6. doi: 10.1016/j.arcmed.2014.02.001. Epub 2014 Apr 13.
2
Regarding the article: Hepatic ischemia/reperfusion injury is diminished by atorvastatin in Wistar rats.关于这篇文章:阿托伐他汀可减轻Wistar大鼠的肝脏缺血/再灌注损伤。
Arch Med Res. 2014 Jul;45(5):439-40. doi: 10.1016/j.arcmed.2014.06.002. Epub 2014 Jun 14.
3
Reply: Regarding the article: Hepatic ischemia/reperfusion injury is diminished by atorvastatin in Wistar rats.回复:关于文章《阿托伐他汀减轻Wistar大鼠肝脏缺血/再灌注损伤》
Arch Med Res. 2014 Jul;45(5):441-2. doi: 10.1016/j.arcmed.2014.06.003. Epub 2014 Jun 14.
4
Different patterns of intestinal response to injury after arterial, venous or arteriovenous occlusion in rats.大鼠动脉、静脉或动静脉闭塞后肠道对损伤的不同反应模式。
World J Gastroenterol. 2009 Aug 21;15(31):3901-7. doi: 10.3748/wjg.15.3901.
5
Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers.阿托伐他汀不能预防胆汁淤积性大鼠肝脏的缺血再灌注损伤。
BMC Surg. 2017 Apr 11;17(1):35. doi: 10.1186/s12893-017-0235-9.
6
Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.阿托伐他汀通过 Toll 样受体 4 抑制和内皮型一氧化氮合酶激活来保护肥胖小鼠免受肝缺血再灌注损伤。
J Gastroenterol Hepatol. 2012 Aug;27(8):1353-61. doi: 10.1111/j.1440-1746.2012.07123.x.
7
Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats.阿托伐他汀可预防果糖诱导的胰岛素抵抗大鼠缺血再灌注损伤。
Cardiovasc Drugs Ther. 2011 Aug;25(4):285-97. doi: 10.1007/s10557-011-6312-x.
8
Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).评价高胆固醇血症患者血清丙氨酸氨基转移酶浓度升高时使用 HMG-CoA 还原酶抑制剂的短期安全性和疗效:PITCH 研究(普伐他汀与阿托伐他汀评价对高胆固醇血症合并轻中度肝损伤患者的疗效)。
J Clin Lipidol. 2012 Jul-Aug;6(4):340-51. doi: 10.1016/j.jacl.2012.01.009. Epub 2012 Feb 4.
9
The effects of NMDA receptor antagonists over intestinal ischemia/reperfusion injury in rats.NMDA 受体拮抗剂对大鼠肠缺血/再灌注损伤的影响。
Eur J Pharmacol. 2009 Oct 25;621(1-3):78-85. doi: 10.1016/j.ejphar.2009.08.038. Epub 2009 Sep 13.
10
Protective effects of N-acetylcystein and atorvastatin against renal and hepatic injury in a rat model of intestinal ischemia-reperfusion.N-乙酰半胱氨酸和阿托伐他汀对大鼠肠缺血再灌注模型肾肝损伤的保护作用。
Biomed Pharmacother. 2017 May;89:673-680. doi: 10.1016/j.biopha.2017.02.086. Epub 2017 Mar 6.

引用本文的文献

1
Evaluation of Indigo carmine on hepatic ischemia and reperfusion injury.靛胭脂对肝脏缺血再灌注损伤的评估。
Acta Cir Bras. 2020 Sep 23;35(9):e202000901. doi: 10.1590/s0102-865020200090000001. eCollection 2020.
2
Protective effect of electro-acupuncture on liver ischemia-reperfusion injury in rats.电针对大鼠肝脏缺血再灌注损伤的保护作用
Exp Ther Med. 2018 Aug;16(2):1373-1380. doi: 10.3892/etm.2018.6287. Epub 2018 Jun 12.
3
Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.治疗肝脏缺血再灌注损伤的新靶点。
Int J Mol Sci. 2018 Apr 26;19(5):1302. doi: 10.3390/ijms19051302.
4
Quercetin and tin protoporphyrin attenuate hepatic ischemia reperfusion injury: role of HO-1.槲皮素和锡原卟啉减轻肝缺血再灌注损伤:HO-1 的作用。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Sep;390(9):871-881. doi: 10.1007/s00210-017-1389-9. Epub 2017 Jun 6.
5
Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers.阿托伐他汀不能预防胆汁淤积性大鼠肝脏的缺血再灌注损伤。
BMC Surg. 2017 Apr 11;17(1):35. doi: 10.1186/s12893-017-0235-9.
6
Effects of preoperative statin on liver reperfusion injury in major hepatic resection: a pilot study.术前他汀类药物对肝大部切除术中肝脏再灌注损伤的影响:一项初步研究。
Updates Surg. 2016 Jun;68(2):191-7. doi: 10.1007/s13304-016-0370-3. Epub 2016 May 10.
7
Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion.三硫酸二糖可减轻钙超载并保护肝脏缺血/再灌注继发的肝损伤。
PLoS One. 2016 Feb 22;11(2):e0149630. doi: 10.1371/journal.pone.0149630. eCollection 2016.
8
Emerging concepts in liver graft preservation.肝脏移植保存的新观念
World J Gastroenterol. 2015 Jan 14;21(2):396-407. doi: 10.3748/wjg.v21.i2.396.